Class information for:
Level 1: IGF 1R//INSULIN LIKE GROWTH FACTOR 1 RECEPTOR//IGF IR

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1521 2527 46.2 90%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
120 23422 GROWTH HORMONE//GROWTH HORMONE & IGF RESEARCH//INSULIN LIKE GROWTH FACTOR I

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 IGF 1R Author keyword 54 37% 5% 116
2 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR Author keyword 41 41% 3% 79
3 IGF IR Author keyword 38 41% 3% 72
4 CIXUTUMUMAB Author keyword 27 78% 1% 18
5 FIGITUMUMAB Author keyword 18 67% 1% 16
6 PICROPODOPHYLLIN Author keyword 17 72% 1% 13
7 IGF I RECEPTOR Author keyword 14 24% 2% 51
8 CP 751 871 Author keyword 12 86% 0% 6
9 NVP AEW541 Author keyword 11 65% 0% 11
10 IGF 1R INHIBITOR Author keyword 11 100% 0% 6

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 IGF 1R 54 37% 5% 116 Search IGF+1R Search IGF+1R
2 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR 41 41% 3% 79 Search INSULIN+LIKE+GROWTH+FACTOR+1+RECEPTOR Search INSULIN+LIKE+GROWTH+FACTOR+1+RECEPTOR
3 IGF IR 38 41% 3% 72 Search IGF+IR Search IGF+IR
4 CIXUTUMUMAB 27 78% 1% 18 Search CIXUTUMUMAB Search CIXUTUMUMAB
5 FIGITUMUMAB 18 67% 1% 16 Search FIGITUMUMAB Search FIGITUMUMAB
6 PICROPODOPHYLLIN 17 72% 1% 13 Search PICROPODOPHYLLIN Search PICROPODOPHYLLIN
7 IGF I RECEPTOR 14 24% 2% 51 Search IGF+I+RECEPTOR Search IGF+I+RECEPTOR
8 CP 751 871 12 86% 0% 6 Search CP+751+871 Search CP+751+871
9 NVP AEW541 11 65% 0% 11 Search NVP+AEW541 Search NVP+AEW541
10 IGF 1R INHIBITOR 11 100% 0% 6 Search IGF+1R+INHIBITOR Search IGF+1R+INHIBITOR

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 FACTOR I RECEPTOR 94 20% 17% 422
2 IGF 1 RECEPTOR 80 58% 4% 92
3 FACTOR IGF I 71 30% 8% 199
4 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR 60 64% 2% 58
5 MONOCLONAL ANTIBODY CP 751 871 54 73% 2% 41
6 SOMATOMEDIN RECEPTOR 48 76% 1% 34
7 RAT GLIOBLASTOMA 39 57% 2% 46
8 FACTOR BINDING PROTEIN 3 34 17% 7% 177
9 CYCLOLIGNAN PPP 33 77% 1% 23
10 SEQUENCE REPEAT 29 67% 1% 26

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
The insulin and insulin-like growth factor receptor family in neoplasia: an update 2012 246 83 39%
Insulin and insulin-like growth factor signalling in neoplasia 2008 786 150 34%
The insulin-like growth factor system and cancer 2003 639 62 77%
The role of the IGF system in cancer growth and metastasis: Overview and recent insights 2007 478 322 42%
Insulin-like growth factors and neoplasia 2004 763 144 49%
Minireview: IGF, Insulin, and Cancer 2011 97 58 52%
Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions 2009 162 73 62%
Disrupting insulin-like growth factor signaling as a potential cancer therapy 2007 186 97 64%
Targeting the Insulin-like Growth Factor Axis for the Development of Novel Therapeutics in Oncology 2012 37 22 95%
Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer 2014 8 135 67%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 OSI ONCOL 9 83% 0.2% 5
2 IGF GRP 6 80% 0.2% 4
3 CANC PREVENT UNIT 4 16% 0.9% 22
4 SECT CANC PREVENT CONTROL 4 41% 0.3% 7
5 ONCOLCANC PREVENT UNIT 3 57% 0.2% 4
6 N GLAMORGAN TRUST 3 100% 0.1% 3
7 IST MED INTERNA MALATTIE ENDOCRINE METAB 3 26% 0.4% 9
8 MEDCANC PREVENT UNIT 3 60% 0.1% 3
9 ONCOL THER EUT AREA 3 42% 0.2% 5
10 OSPED GARIBALDI 2 17% 0.5% 13

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000142703 DIPARTIMENTO SCI MED DIAGNOST//HEPATOL 5//PL MOL MED IMMA BOADILLA DEL MONTE
2 0.0000131587 IGFBP 5//INSULIN LIKE GROWTH FACTOR BINDING PROTEIN//IGFBP 3
3 0.0000083411 METFORMIN//ANTIDIABETIC BIGUANIDES//GLARGINE
4 0.0000075784 SALFORD ROYAL HOSP UNIV TRUST//MED 0613B//MED HUMAN LIFE SCI
5 0.0000073316 INSULIN RECEPTOR SUBSTRATE//INSULIN RECEPTOR SUBSTRATE 1//IRS 1
6 0.0000070975 ENDOCRINE POLYPEPTIDE CANC//GHRH ANTAGONISTS//GHRH ANTAGONIST
7 0.0000058399 IGFBP7//IGFBP 7//MAC30
8 0.0000053916 LEPRECHAUNISM//INSULIN RECEPTOR//DONOHUE SYNDROME
9 0.0000050120 NON ISLET CELL TUMOR HYPOGLYCEMIA NICTH//BIG IGF II//NICTH
10 0.0000049444 MECHANO GROWTH FACTOR//MECHANO GROWTH FACTOR MGF//IGF 1 ISOFORMS